AstraZeneca and researchers of IDIBELL met to identify opportunities for collaboration. AstraZeneca is one of the leading companies in research and drug development. It is present in nearly twenty countries worldwide.

They discussed: -the possibility of generating spin-offs from research groups that could fit the activity of the Pharmaceutical and could create opportunities for technology transfer such as patenting or licensing, -as well as seeking strategies for collaboration in infrastructure or the study of results in health care.

The pharmaceutical company AstraZeneca is studying ways of collaboration with IDIBELL

May 2011

Notícies relacionades |Noticias relacionadas | Related news

Comments are closed.

Home | eHub | Email